Zoekresultaten voor

Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Auteurs: M. van Wely et al.Tijdschrift: Cochrane Database Syst Rev, Februari 2011 BACKGROUND Several systematic reviews compared recombinant gonadotrophin with urinary gonadotrophins (HMG, purified FSH, highly purified FSH) for ovarian hyperstimulation in IVF and ICSI cycles and these reported conflicting results. Each of … Continued

A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. Auteurs: S. Sagnella et al.Tijdschrift: Fertility and Sterility Volume 95, Issue 2, Februari 2011 Objective To demonstrate the noninferiority of highly purified menotropin (HP-hMG) compared with recombinant FSH (rFSH) regarding … Continued

Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40. Auteurs: M. Sbracia et al.Tijdschrift: Fertility and Sterility, Volume 91, Issue 5, Mei 2009 Objective To determine which protocols work better between cetrorelix and long protocols in older patients in a randomized controlled study. Methods Design: … Continued

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Auteurs: S. Ziebe et al.Tijdschrift: Human Reproduction, Volume 22, Issue 9, September 2007 Background There are limited data on the impact of different gonadotrophin preparations on embryo quality. Methods This evaluation was part of a randomized, assessor-blind, multinational … Continued

Ovarian stimulation protocols (anti‐oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Auteurs: A. Cantineau, B. CohlenTijdschrift: Cochrane Database Syst Rev, April 2007 Background Intrauterine insemination (IUI) combined with ovarian hyperstimulation (OH) has been demonstrated to be an effective form of treatment for subfertile couples. Several ovarian stimulation protocols … Continued

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial Auteurs: A. Nyboe Andersen, P. Devroey, J-C. ArceTijdschrift: Human Reproduction, Volume 21, Issue 12, December 2006 Background LH activity may influence treatment response and outcome in IVF cycles. Methods A randomized, assessor-blind, multinational trial compared … Continued

Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Auteurs: J. Smitz, A.N. Andersen, P. Devroey, J.-C. ArceTijdschrift: Human Reproduction, Volume 22, Issue 3, Maart 2007 Background Highly purified menotrophin (HP-hMG) has been associated with fewer oocytes retrieved and a higher proportion of top-quality embryos … Continued